Japan's audit board has requested the health ministry provide supporting documentation for contracts with U.S and British coronavirus vaccine manufacturers after finding a weak basis for ordering a total of 882 million doses in fiscal 2020 and 2021.The report released Wednesday by the Board of Audit of Japan also found that at least 30 percent of the doses were either canceled or disposed of after expiring.The Ministry of Health, Labor and Welfare spent a total of 4.20 trillion yen ($32 billion) in the two years, with the cost of securing vaccines accounting for 2.40 trillion yen of the amo…READ FULL ARTICLE